Allergy News From Medical News Today

Allergy News From Medical News Today Sat, 04 Feb 2012 11:37:25 +0100 Some Allergic Inflammation May Be Due To Exposure To Common Environmental Bacteria Could some cases of asthma actually be caused by an allergic reaction to a common environmental bacteria? New research findings published in the Journal of Leukocyte Biology suggests that this idea may not be as far-fetched as it seems. In a research report appearing in the February 2012 print issue, researchers show a link between common environmental bacteria and airway inflammation... Wed, 01 Feb 2012 01:00:00 PST Researchers Discover Dual Role Of Key Player In Immune System Northwestern University Feinberg School of Medicine researchers have identified a new and unusual role for a key player in the human immune system. A protein initially believed to regulate one routine function within the cell has proven vital for another critical step in the activation of the immune system... Tue, 31 Jan 2012 00:00:00 PST Genetic Mutation Leads To Cold Allergy, Immune Deficiency And Autoimmunity Investigators at the National Institutes of Health have identified a genetic mutation in three unrelated families that causes a rare immune disorder characterized by excessive and impaired immune function. Symptoms of this condition include immune deficiency, autoimmunity, inflammatory skin disorders and cold-induced hives, a condition known as cold urticaria... Fri, 13 Jan 2012 00:00:00 PST Get Ready For Spring - Hay Fever Worse In Spring Than Summer Hay fever (runny nose, sneezing, itchy eyes) is caused by an allergy to pollen, and most commonly to grass pollen. These tiny grains bring misery to sufferers through spring and summer and pollen levels are often included as part of weather reports to help sufferers prepare... Sat, 31 Dec 2011 00:00:00 PST Perrigo Announces FDA Final Approval For Desloratadine Perrigo Company (Nasdaq: PRGO;TASE) announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Desloratadine tablets (5 mg). Perrigo had been sued for patent infringement based upon its filing of an ANDA containing a Paragraph IV certification and settled the case in 2008... Thu, 29 Dec 2011 01:00:00 PST